BiotechTube
Home/Guardian Therapeutics/Shuhao Zhu, PhD
SZ

Shuhao Zhu, PhD

CSO, Co-Founder

Guardian Therapeutics

Therapeutic Areas

HematologyGastroenterologyDermatologyOncologyImmunology

Guardian Therapeutics Pipeline

DrugIndicationPhase
BT200 (inferred)Thrombotic/Hematologic Disorder (targets vWF A1 domain)Pre-clinical
ApDC Oncology PlatformOncology (unspecified)Pre-clinical
Gastroenterology ProgramGastrointestinal Disorder (unspecified)Pre-clinical
Dermatology ProgramDermatologic Disorder (unspecified)Pre-clinical

Leadership Team at Guardian Therapeutics

JG
Jim Gilbert, MD
CEO, Co-Founder
View full Guardian Therapeutics profile